BioSpace News Archive

Lone Star Bio

The Caris Precision Oncology Alliance Welcomes the Icahn School of Medicine at Mount Sinai

Caris Life Sciences® announced that the Icahn School of Medicine at Mount Sinai, in New York, NY, has joined the Caris Precision Oncology Alliance™ and will collaborate with Caris on various research projects.

July 6, 2023
·
4 min read
Drug Development

Revive Therapeutics Announces Results of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Revive Therapeutics Ltd. announced results of the Company’s Phase 3 clinical trial evaluating the safety and efficacy of oral Bucillamine in patients with mild to moderate COVID-19.

July 6, 2023
·
6 min read
Drug Development

Hexvix®, A Diagnostic Drug for Bladder Cancer of Asieris has Completed the Phase III bridging trial Enrollment

Asieris Pharmaceuticals announced the completion of patient enrollment for its Phase III bridging clinical trial of Hexvix®, a drug used for the diagnosis of bladder cancer.

July 6, 2023
·
3 min read
BioMidwest

Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs

NanoViricides, Inc. reports that the clinical trial of its broad-spectrum antiviral drug NV-CoV-2 is progressing satisfactorily.

July 6, 2023
·
9 min read
Genetown

ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit

ProQR Therapeutics NV. today announced a presentation at the RNA Editing Summit, July 11-13, 2023 in Boston, MA, USA.

July 6, 2023
·
4 min read
Biosimilar BYOOVI now reimbursed in Quebec to treat serious retinal disorders

Biogen Canada Inc. is pleased to announce that Quebec has become the first province to reimburse Pr BYOOVIZ™ (ranibizumab injection), an anti-vascular endothelial growth factor (anti-VEGF) biosimilar therapy for certain eye conditions affecting the retina.

July 6, 2023
·
4 min read
Append Medical Raises $4.35M in Initial Closing of Extended Series A Round

Append Medical has raised $4.35 million as part of an extended series A Round.

July 6, 2023
·
2 min read
Business

INOVIQ and Promega Announce Global Joint Marketing Agreement for EXO-NET Exosome Isolation and Nucleic Acid Purification Solutions

INOVIQ and Promega sign a global joint marketing agreement for INOVIQ’s EXO-NET® exosome capture technology and Promega Nucleic Acid purification systems.

July 6, 2023
·
5 min read
Pharm Country

Trevi Therapeutics to Participate in Upcoming July Investor Events

Trevi Therapeutics, Inc. today announced senior management will attend and participate in the following investor events in July.

July 6, 2023
·
1 min read
Biotech Beach

Introducing Tenovi Cellular-Enabled Infrared Thermometer: Remote Patient Monitoring with FDA-cleared Advanced Temperature Monitoring Technology

Leading remote patient monitoring (RPM) solution innovator, Tenovi has released its cellular-enabled Infrared Thermometer.

July 6, 2023
·
2 min read